Literature DB >> 33903133

Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.

Leora Branfield Day1, Husam Abdel-Qadir1, Michael Fralick2.   

Abstract

Entities:  

Year:  2021        PMID： 33903133     DOI： 10.1503/cmaj.210300

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.

Authors:  Safa Al-Jammali; Rana Al-Zakhari; Nicholas Sheets; Arun Mahtani; Veronika Stefanishina; Nidal Isber
Journal:  Cardiol Res       Date:  2022-05-10

Review 2.  Safety profile of COVID-19 drugs in a real clinical setting.

Authors:  Mei Nee Chiu; Maitry Bhardwaj; Sangeeta Pilkhwal Sah
Journal:  Eur J Clin Pharmacol       Date:  2022-01-28       Impact factor: 3.064

3.  Complete AV Block in Vaccinated COVID-19 Patient.

Authors:  Kevin Lee; Osman Rahimi; Neelesh Gupta; Chowdhury Ahsan
Journal:  Case Rep Cardiol       Date:  2022-03-30

4.  Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.

Authors:  Natale Wasef; Steven Hamilton; Tehreem Fatima; Eric Osgood
Journal:  Cureus       Date:  2022-07-26

5.  Remdesivir therapy associated with Bradycardia in SARS-CoV2.

Authors:  Sabina Kumar; Christina Arcuri; Sumanta Chaudhuri; Rahul Gupta; Mahendra Aseri; Pranav Barve; Shivang Shah
Journal:  Clin Cardiol       Date:  2021-07-28       Impact factor: 3.287
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.